top of page
Narcolepsy Type 1
From Misunderstood Symptoms to Mechanism-Based, Patient-Centered Care Across the Evolving Treatment Landscape
In this 60-minute expert-led activity, Amber Hoberg, MSN, APRN, PMHNP-BC, and Lois Krahn, MD, explore practical strategies to recognize narcolepsy type 1 (NT1), apply the mechanism of action of OX2R-selective agonists to the underlying orexin deficiency, address diagnostic disparities, and support patient-centered care. Includes an expert presentation, medical animation, and interactive knowledge checks.
Narcolepsy Type 1:
Treating the Root Cause, Often Missed, Now Recognized
This 4.25-minute medical animation brings the biology of NT1 to life, showing how loss of orexin-producing neurons disrupts wake-sleep regulation and contributes to the symptoms and burden of the disease. See how orexin deficiency drives NT1 and why the orexin pathway has emerged as an important therapeutic target.
Featured Content From the Main Activity
bottom of page